孕妇易栓三项活性、D-二聚体、同型半胱氨酸水平与胎儿生长受限的相关性分析

doi:10.3969/j.issn.1671-7171.2025.09.004

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1272 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】 To explore the correlation between the activity of thrombophilia three indices [protein C(PC), protein S(PS), antithrombin-Ⅲ(AT-Ⅲ)], D-dimer, homocysteine(Hcy) levels in pregnant women and fetal growth restriction(FGR).【Methods】 A total of 38 pregnant women with FGR admitted to our hospital from January 2023 to January 2024 were selected as the FGR group, and 40 healthy pregnant women who delivered in our hospital during the same period were selected as the control group. Enzyme-linked immunosorbent assay(ELISA) was used to detect the activity of thrombophilia three indices, D-dimer, and Hcy levels in both groups. Logistic multivariate regression analysis was used to analyze their correlation with FGR.【Results】 The PC activity and AT-Ⅲ activity in the FGR group were lower than those in the control group, while the levels of D-dimer and Hcy were higher than those in the control group. The fetal tibial length, biparietal diameter, and head circumference in the FGR group were shorter/smaller than those in the control group, with statistically significant differences(P<0.05). Correlation analysis showed that PC activity, AT-Ⅲ activity, D-dimer, and Hcy levels were significantly correlated with FGR(P<0.05). Logistic multivariate regression analysis showed that low PC activity, low AT-Ⅲ activity, high D-dimer level, and high Hcy level were risk factors for FGR in pregnant women(P<0.05).【Conclusion】 Low PC activity, low AT-Ⅲ activity, high D-dimer level, and high Hcy level in pregnant women are significantly correlated with the occurrence of FGR. PC activity, AT-Ⅲ activity, D-dimer, and Hcy can be used as important markers to predict FGR in pregnant women, which is helpful for early diagnosis and prevention of FGR.

Key words： Fetal Growth Retardation Fibrin Fibrinogen Degradation Products Cysteine

Received: 13 June 2025

PACS:

R714.431

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHANG Qing
	ZHOU Bin
	GUO Shuhuan

Cite this article:

ZHANG Qing,ZHOU Bin,GUO Shuhuan. Correlation Analysis of Pregnant Women's Thrombophilia Three Indices Activity, D-Dimer, and Homocysteine Levels with Fetal Growth Restriction[J]. JOURNAL OF CLINICAL RESEARCH, 2025, 42(9): 1502-1504.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2025.09.004 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2025/V42/I9/1502

[1] 卫仙洪,何霞,李玲,等. 子痫前期血清中血管生成抑制蛋白1水平与胎儿生长受限的相关性分析[J].安徽医药,2024,28(9):1862-1865.
[2] 郭雯婷,张燕,王晋. 妊娠期糖尿病患者血管内皮功能和氧化应激水平与早发型胎儿生长受限的相关性分析[J].中国医药导刊,2023,25(3):292-296.
[3] 张露萍,李晋月,杨忠. 基于Lasso-Logistic回归构建晚发型胎儿生长受限列线图预测模型[J].影像科学与光化学,2025,43(1):48-54.
[4] 罗艳,郑文佩,任为. 生物标志物在胎儿生长受限早期诊断中的研究进展[J].中国计划生育和妇产科,2024,16(11):40-42.
[5] 肖柔,胡凌云,王晓萍,等. 单胎妊娠胎儿生长受限的危险因素及其对胎儿结局的影响[J].武警医学,2024,35(11):944-947.
[6] 谢幸,孔北华. 妇产科学[M].9 版.北京:人民卫生出版社,2018:135.
[7] 陈陆静,钱坤,马秋林,等. 血清外泌体miR-494水平与妊娠期胎儿生长受限的关系[J].山东医药,2024,64(17):75-78.
[8] 王宏艳,徐志文,孙晓东,等. 胎儿生长受限患者胎盘组织中VEGFA、HIF-1α表达及临床意义[J].中国计划生育学杂志,2024,32(7):1663-1667.
[9] 黄祚,林宁. 脐动脉血流彩色多普勒超声参数可评估胎儿生长受限[J].分子影像学杂志,2024,47(12):1341-1346.
[10] 信艳萍,王雅莉,李瓅,等. 川芎嗪对实验性手术胎儿生长受限大鼠胎儿发育的影响及机制[J].西北药学杂志,2024,39(4):81-85.
[11] 徐霞,许艳红,祖逸峥,等. 先于子痫前期的严重胎儿生长受限的临床特点及围产结局[J].中华围产医学杂志,2024,27(9):722-728.
[12] 陈丽,卢国萍,刘芙蓉. 血清Ghrelin、VEGF-A水平对妊娠期糖尿病患者早发型胎儿生长受限的预测价值[J].新疆医科大学学报,2024,47(5):699-703.
[13] 王凤梅,杨悦,李娜. 子痫前期孕妇脐动脉血流参数及血清PLGF和VEGF水平与胎儿生长受限的关系[J].山东医药,2024,64(25):87-90.
[14] 高海侠,张晓月,高京京,等. 子痫前期孕妇血清miR-424、miR-31-5p水平与胎儿生长受限的相关性分析[J].检验医学与临床,2024,21(20):3048-3052.
[15] 杨梅琳,党志霞,陈盈珏,等. 母体血清胎盘生长因子联合中期唐氏筛查对胎儿生长受限的预测分析[J].福建医科大学学报,2024,58(1):61-66.